Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Kate Johnson

    News

    Neurologists Lack Awareness of Steroid Toxicity

    Author:
    Kate Johnson
    Publish date: October 28, 2024

    Over 85% of survey respondents indicated that a tool for systematically monitoring corticosteroid toxicity would be valuable.

    • Read More

    News

    Veterans Affairs Hailed as a ‘Bright Spot’ in ALS Care

    Author:
    Kate Johnson
    Publish date: October 28, 2024

    Transdisciplinary collaboration is essential for maintaining an effective system.

    • Read More

    News

    Digital Tool May Help Neurologists Assess Steroid Toxicity

    Author:
    Kate Johnson
    Publish date: October 28, 2024

    The study results “indicate that patients with MG who initiated steroids demonstrated evidence of steroid toxicity in as little as 90 days after...

    • Read More

    News

    Remote Assessments: A Win-Win for ALS Patients and Clinics?

    Author:
    Kate Johnson
    Publish date: October 24, 2024

    Remote monitoring of patients with ALS is a feasible option for both maximizing quality of life and minimizing cost and disruption.

    • Read More

    News

    Sustained Control with Investigational Monoclonal Antibody for Myasthenia Gravis

    Author:
    Kate Johnson
    Publish date: October 17, 2024

    The VIVACITY-MG3 trial is the first registrational study of a neonatal fragment crystallizable receptor blocker to show sustained efficacy through...

    • Read More

    News

    First-in-Class B-Cell Depleting Agent Promising for Myasthenia Gravis

    Author:
    Kate Johnson
    Publish date: October 17, 2024

    Although inebilizumab is already FDA-approved for the treatment of neuromyelitis optica, it still faces approval and indication hurdles for MG.

    • Read More

    News

    Antidepressants Linked to Improved Verbal Memory

    Author:
    Kate Johnson
    Publish date: October 1, 2024

    The clinical effect may be linked to changes in serotonin 4 (5-HT4) receptor levels in the brain.

    • Read More

    News

    Heightened Amygdala Activity Tied to Postpartum Depression

    Author:
    Kate Johnson
    Publish date: October 1, 2024

    “Pregnant women with higher amygdala activity were less able to regulate their emotions successfully compared to those with less amygdala activity...

    • Read More

    News

    Neuromyelitis Optica: Historically Misdiagnosed — Now Demands Prompt Treatment

    Author:
    Kate Johnson
    Publish date: September 30, 2024

    Rapid diagnosis and treatment of NMO “means potentially preventing future devastating neurologic inju......

    • Read More

    News

    Can Hormones Guide Sex-Specific Treatments for Alcohol Use Disorder?

    Author:
    Kate Johnson
    Publish date: September 30, 2024

    “Sex hormones may modulate treatment response, potentially supporting sex-specific pharmacological intervention.”

    • Read More

    News

    Expert Calls for Research into GLP-1s for Mental Illness

    Author:
    Kate Johnson
    Publish date: September 26, 2024

    Current research investigating GLP-1s in psychiatry and neurology is increasingly focused on neuroinflammation.

    • Read More

    News

    Psilocybin Bests SSRI for Major Depression in First Long-Term Comparison

    Author:
    Kate Johnson
    Publish date: September 24, 2024

    “The study suggests that psilocybin therapy might be a more holistic treatment option for depression.”

    • Read More

    News

    Liposomal Irinotecan May Be Effective in Later Lines for Pancreatic Cancer

    Author:
    Kate Johnson
    Publish date: August 26, 2024

    Real-world meta-analysis finds benefit of later-line liposomal irinotecan is not attenuated by prior conventional irinotecan.

    • Read More

    News

    Study Identifies Oral Antibiotics Linked to Severe Cutaneous Reactions

    Author:
    Kate Johnson
    Publish date: August 12, 2024

    The results “underscore the importance of judicious prescribing, with preferential use of antibiotics associated with a lower risk when clinically...

    • Read More

    News

    Outcomes with CDK4/6 Inhibitors Vary in BC

    Author:
    Kate Johnson
    Publish date: July 30, 2024

    A large Italian study found real-world differences in short-term outcomes among first line CDK4/6 inhibitors palbociclib, ribociclib and...

    • Read More

    Pages

    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery